Does AMPHOTERICIN B\TETRACYCLINE Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with AMPHOTERICIN B\TETRACYCLINE. This represents 11.8% of all adverse event reports for AMPHOTERICIN B\TETRACYCLINE.
6
Reports of Interstitial lung disease with AMPHOTERICIN B\TETRACYCLINE
11.8%
of all AMPHOTERICIN B\TETRACYCLINE reports
1
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From AMPHOTERICIN B\TETRACYCLINE?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPHOTERICIN B\TETRACYCLINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does AMPHOTERICIN B\TETRACYCLINE Cause?
Cardiac arrest (19)
Hyperglycaemia (19)
Hyperkalaemia (19)
Hyperlactacidaemia (19)
Hyponatraemia (19)
Blister (12)
Erythema (12)
Toxic epidermal necrolysis (12)
Cholecystitis (11)
Cholelithiasis (11)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)